G17DT - a new weapon in the therapeutic armoury for gastrointestinal malignancy
暂无分享,去创建一个
[1] S. Watson,et al. Expression of gastrin in developing gastric adenocarcinoma , 2001, The British journal of surgery.
[2] S. Watson,et al. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis. , 2001, Cancer research.
[3] S. Watson,et al. Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] S. Watson,et al. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence , 2000, Gut.
[5] H. Hellmich,et al. Human Colorectal Cancers Express a Constitutively Active Cholecystokinin-B/Gastrin Receptor That Stimulates Cell Growth* , 2000, The Journal of Biological Chemistry.
[6] A. Smith,et al. Gastrin and Colorectal Cancer , 2000 .
[7] T. Koh,et al. Gastrin as a growth factor in the gastrointestinal tract , 2000, Regulatory Peptides.
[8] T. Wang,et al. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. , 2000, The Journal of clinical investigation.
[9] P. Guillou,et al. Death from early colorectal cancer is predicted by the presence of transcripts of the REG gene family , 2000, British Journal of Cancer.
[10] J. Rehfeld,et al. Closing the gastrin loop in pancreatic carcinoma , 2000, Cancer.
[11] R. Pounder,et al. A phase II study of gastrimmune in advanced pancreatic cancer , 2000 .
[12] M. Caplin,et al. Towards immunotherapy for pancreatic cancer , 2000, Gut.
[13] M. Chiba,et al. Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease , 2000, Gut.
[14] S. Watson,et al. Review article: gastrin and colorectal cancer. , 2000, Alimentary pharmacology & therapeutics.
[15] T. Morris,et al. A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth , 1999, Gut.
[16] A. Burroughs,et al. Role of Vasoactive Drugs in the Treatment of Bleeding Oesophageal Varices , 1999, Digestion.
[17] T. Morris,et al. Antibodies raised by gastrimmune inhibit the spontaneous metastasis of a human colorectal tumour, AP5LV. , 1999, European journal of cancer.
[18] J. Hardcastle,et al. A comparison of an anti‐gastrin antibody and cytotoxic drugs in the therapy of human gastric ascites in SCID mice , 1999, International journal of cancer.
[19] S. Knuutila,et al. Concomitant gastrin and ERBB2 gene amplifications at 17q12–q21 in the intestinal type of gastric cancer , 1999, Genes, chromosomes & cancer.
[20] Y. Matsuzawa,et al. Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastric epithelial cells transfected with gastrin receptor. , 1999, Gastroenterology.
[21] T. Chiba,et al. Regenerating gene protein may mediate gastric mucosal proliferation induced by hypergastrinemia in rats. , 1998, Gastroenterology.
[22] J. Ajani. Current status of therapy for advanced gastric carcinoma. , 1998, Oncology.
[23] S. Watson,et al. Coexpression of gastrin and gastrin receptors (CCK-B and ΔCCK-B) in gastrointestinal tumour cell lines , 1998, Gut.
[24] S. Watson,et al. Antibodies targeting the amino terminal portion of the human CCKB/gastrin receptor inhibit the liver invasion of a human colonic tumour , 1998 .
[25] T. Morris,et al. Pre‐clinical evaluation of the Gastrimmune immunogen alone and in combination with 5‐fluorouracil/leucovorin in a rat colorectal cancer model , 1998, International journal of cancer.
[26] J. Carmichael. Clinical response benefit in patients with advanced pancreatic cancer. Role of gemcitabine. , 1997, Digestion.
[27] T. Morris,et al. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. , 1996, Cancer research.
[28] J. Robertson,et al. Anti‐gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5 , 1995, International journal of cancer.
[29] S. Watson,et al. Gastric acid suppression using anti-gastrin-17 antibodies produced by a gastrin immunogen, gastrimmune, in an in vivo pig model , 1995 .
[30] A. Miyake. A truncated isoform of human CCK-B/gastrin receptor generated by alternative usage of a novel exon. , 1995, Biochemical and biophysical research communications.
[31] J. Neoptolemos,et al. Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study , 1995, The British journal of surgery.
[32] T. Morris,et al. A hepatic invasive human colorectal xenograft model. , 1993, European journal of cancer.
[33] F. Mícek. [Cancer of the pancreas]. , 1965, Bratislavske lekarske listy.